Precision Medicine in Relapsed and Refractory Childhood Cancers: Single-center Experience, Literature Review, and Meta-analysis
Objective: To date, the understanding of pediatric tumor genomics and how these genetic aberrations correlate with clinical outcome is lacking. Here, we report our experience with the next-generation sequencing (NGS) test program and discuss implications for the inclusion of molecular profiling into...
Main Authors: | Oz Mordechai, Myriam Weyl Ben-Arush |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2018-07-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | https://www.rmmj.org.il/issues/38/863/manuscript |
Similar Items
-
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial
by: Rebecca Daly, et al.
Published: (2023-06-01) -
Neuroblastoma in the Era of Precision Medicine: A Clinical Review
by: Andrew Wahba, et al.
Published: (2023-09-01) -
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
by: Michal Kýr, et al.
Published: (2020-03-01) -
Genomics-Driven Precision Medicine in Pediatric Solid Tumors
by: Praewa Suthapot, et al.
Published: (2023-02-01) -
Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations
by: Fabio Pastorino, et al.
Published: (2022-09-01)